Built-in Calculator Optimizes Continuous Veno-venous Hemofiltration Prescription and Improves Therapeutic Quality in Critically-ill Acute Kidney Injury Patients
- Conditions
- Built-in CulculatorCVVHFiltration Fraction
- Registration Number
- NCT05638711
- Lead Sponsor
- Taipei Medical University
- Brief Summary
- The goal of this observational study is to compare in ICU patients received CVVH treatment. The main questions it aims to answer are: 
 Control of Filtration fraction by built-in calculator
 * Reduced filter clotting and prolong filter lifespan
 * Improve patient mortality Participants will divided into before group and after group based on the day when built-in calculator for calculating Filtration fraction was utilized.
 Researchers will compare before group to see if there were differences in clotting events, filter downtime, filter lifespan, mortality, etc.
- Detailed Description
- # built-in calculator for calculating Filtration fraction 
 * The calculator was built in prescription system since 2020/10/01
 * providing tempt filtration fraction for operators to adjust CVVH dose
 * the protocol of patient care didn't change between before and after group.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1
- ICU patients received CVVH during 2019~2021 (3 years) in our hospital
- under age of 20, pregnant, or with HIV infection
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Mortality - 30 days, 60 days, "through study completion, an average of 1.5 year" mortality in ICU and in Hospital - Patient death 
- Secondary Outcome Measures
- Name - Time - Method - electrolytes_2 - the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) - K - electrolytes_4 - the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) - P - acid-base balance_2 - the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) - bicarbonate - Filter downtime - "through the complete treatment course hours, an average of 24 hours" - downtime between filter replacement - electrolytes_1 - the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) - Filter clotting events - "through the complete treatment course hours, an average of 24 hours" - Filter clotting events - Filter lifespan - "through the complete treatment course hours, an average of 24 hours" - average treatment time per filter - acid-base balance_1 - the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) - pH - others_2 - the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) - platelet - electrolytes_3 - the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) - Ca - others_1 - the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) - body temperature 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
- Shuang-Ho Hospital 🇨🇳- New Taipei City, Zhonghe District, Taiwan Shuang-Ho Hospital🇨🇳New Taipei City, Zhonghe District, Taiwan
